证券代码：603341 证券简称：龙旗科技 公告编号：2025-089 上海龙旗科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据《上市公司募集资金监管规则》《上海证券交易所股票上市规则》《上 海证券交易所上市公司自律监管指引第 1 号——规范运作》等有关规定，现将上 海龙旗科技股份有限公司（以下简称"公司"）2025 年半年度募集资金存放、 管理与使用情况作如下专项报告： 一、募集资金基本情况 （一）实际募集资金金额及资金到账情况 根据中国证券监督管理委员会于 2023 年 10 月 25 日出具的《关于同意上海 龙旗科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕2432 号），并经上海证券交易所同意，公司首次公开发行人民币普通股 60,000,000 股，每股面值为人民币 1.00 元，发行价格为人民币 26.00 元/股，募集资金总额 为 人民币 156,000.00 万 元，扣除发行 费用后，实 际募集资 金净额 为人 民 币 了《上海龙旗科技股份有限公司验资报告》（容诚验字[2 ...

Fundraising Overview - The company raised a total of RMB 260 million through the issuance of 40 million shares at RMB 6.5 per share, with net proceeds after expenses amounting to RMB 209.17 million [1] - As of June 30, 2025, the company has utilized RMB 196.61 million of the raised funds, leaving a balance of RMB 12.78 million [1][6] - The company received RMB 1.75 million in interest income and investment returns from cash management products [1] Fund Management - The company has established a fundraising management system to ensure the proper use of raised funds, adhering to relevant laws and regulations [2] - A tripartite supervision agreement was signed with the underwriter and banks to manage the special account for raised funds [2] - As of June 30, 2025, the total balance in the fundraising accounts was RMB 65.21 million [4] Cash Management - The company has been authorized to use up to RMB 60 million of temporarily idle raised funds and RMB 100 million of idle self-owned funds for cash management, focusing on safe and liquid investment products [5][8] - All investments made with idle funds have matured as of June 30, 2025, without exceeding the authorized limits [8] Use of Surplus Funds - The company has approved the reallocation of surplus funds from the completion of a project to new initiatives, including RMB 23 million for a new materials recycling industrial park and RMB 10.94 million for supplementing working capital [5][6] - The total amount of surplus funds reallocated is RMB 33.94 million, representing 16.23% of the total raised funds [7] Compliance and Reporting - The company has complied with all relevant regulations regarding the use and disclosure of raised funds, with no violations reported [7]

募集资金管理制度 第一章 总则 第一条 为了规范宁波柯力传感科技股份有限公司（以下简称"公司"） 募集资金的使用与管理，提高募集资金使用效益，保护投资者的合法权益，根 据《中华人民共和国公司法》《中华人民共和国证券法》《上海证券交易所股 票上市规则》《上市公司募集资金监管规则》等有关法律、法规以及《宁波柯 力传感科技股份有限公司章程》（以下简称"《公司章程》"）的相关规定， 并结合公司实际情况，特制定本制度。 第二条 本制度所称募集资金系指公司通过公开发行证券（包括首次公开 发行股票、配股、增发、发行可转换公司债券、发行分离交易的可转换公司债券 等）以及非公开发行证券向投资者募集的资金，但不包括公司实施股权激励计 划募集的资金。 宁波柯力传感科技股份有限公司 第三条 公司董事会应建立募集资金存储、使用和管理的内部控制制度， 对募集资金存储、使用、变更、监督和责任追究等内容进行明确规定。 公司应当将募集资金存储、使用和管理的内部控制制度及时报上海证券交 易所（以下简称"上交所"）备案并在上交所网站上披露。 第四条 公司的董事和高级管理人员应当勤勉尽责，确保公司募集资金安 全，不得操控公司擅自或者变相改变募集资金 ...

国金证券股份有限公司 公司新增募集资金专户的开设情况具体如下： | | | | | 存 入 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 公司名称 | 募集资金专户存储银行 | | | 账号 | | | 用途 | | | | | | 金 | | | | | | | | | 额 | | | | | | 汇丰银行（中国）有限公司 | | | | | | 爱柯迪 | | 爱柯迪（马来西 | | | 020-093811-057 | | 0 | 智能制 | | | 亚）有限公司（IKD | | | | | | | | | (MALAYSIA) | | | | | | | | | | | | | | 产业园 | | | | SDN.BHD.） | INDUSTRIAL | AND | | | | | | 项目 COMMERCIAL BANK OF 关于爱柯迪股份有限公司 新增募集资金专项账户并签署监管协议的核查意见 国金证券股份有限公司（以下简称"国金证券"或"保荐机构"）作为爱柯 迪股份有限公司（以下简称"爱柯迪"或"公司"）公开发行可转换公司 ...

Summary of Key Points Core Viewpoint The report outlines the fundraising activities and the status of the funds raised by Seirus Medical Technology Group Co., Ltd. It highlights the termination of certain fundraising projects and the reallocation of remaining funds to enhance liquidity and operational efficiency in response to changing market conditions. Fundraising Overview - In 2018, the company raised approximately RMB 625.96 million through a non-public offering of A-shares, with a net amount of RMB 607.61 million after expenses [1][2] - As of June 30, 2025, the remaining balance of the non-public fundraising was RMB 8.99 million, including interest [2] Fund Usage and Management - By June 30, 2025, the company had utilized RMB 202.78 million of the funds raised from the 2020 convertible bond issuance, leaving a balance of RMB 333.89 million [4] - The company has established dedicated bank accounts for the management of the raised funds, ensuring compliance with regulatory requirements [7][18] Project Termination and Fund Reallocation - The company decided to terminate the "Expansion of Medical Testing Integrated Marketing and Service Business Scale Project" due to significant changes in the market environment and profitability concerns, reallocating the remaining RMB 172.54 million to enhance liquidity [28][29] - The decision was made after thorough evaluations and was approved in board meetings held in June 2025 [28] Financial Management Practices - The company has implemented a structured approach to manage the raised funds, including regular audits and checks by the finance department to ensure proper usage [7][24] - The company has also utilized idle funds temporarily to supplement working capital, with repayments made as scheduled [24][31] Regulatory Compliance - The company has adhered to various regulations regarding fundraising and fund management, including the establishment of tripartite agreements with banks and sponsors to ensure proper oversight [7][18][22]

Fundraising Overview - The company raised a total of RMB 610.55 million through the issuance of convertible bonds, with a net amount of RMB 600.35 million after deducting fees [1] - As of June 30, 2025, the company has utilized RMB 53.13 million of the raised funds, with a remaining balance of RMB 34.82 million [1][3] Fund Management - The company has established a dedicated account for managing the raised funds, in compliance with relevant laws and regulations [2][3] - A tripartite supervision agreement was signed with the underwriter and banks to clarify the rights and obligations of all parties involved [3] Fund Utilization - The company has allocated RMB 42.75 million of the raised funds for the construction of a liquid intelligent packaging production line [3] - The company temporarily supplemented working capital with RMB 50 million from the raised funds, which has positively impacted its operational capacity and financial condition [5] Project Changes - The implementation entity for the liquid intelligent packaging production line project has been changed from Zhejiang Meihua Packaging Machinery Co., Ltd. to Yongchuang Zhiyun (Zhejiang) Machinery Equipment Co., Ltd., with the project location also being updated [5][10] - The changes in project implementation do not affect the purpose, direction, or investment amount of the project [10] Compliance and Reporting - The company has ensured timely, truthful, accurate, and complete disclosure of information related to the raised funds, with no violations in fund management [6]

Core Points - The report details the fundraising and usage status of Wuxi Dekeli Optoelectronic Technology Co., Ltd. for the first half of 2025, ensuring compliance with relevant regulations and protecting investor rights [1][4]. Fundraising Overview - The company raised a total of RMB 1,179,763,200.00 through its initial public offering (IPO) at a price of RMB 48.51 per share, with a net amount of RMB 1,094,353,980.82 after deducting issuance costs [1]. - As of June 30, 2025, the company has used RMB 238,462,655.47 for investment projects and RMB 288,300,000.00 for working capital, leaving a balance of RMB 633,887,328.35 in unused funds [1]. - The company also raised RMB 217,149,951.88 through a simplified procedure for issuing shares to specific targets, with a net amount of RMB 217,149,951.88 and a remaining balance of RMB 117,280,466.63 as of the same date [1][2]. Fund Management - The company has established a fundraising management system to ensure proper use and storage of funds, adhering to laws and regulations [1][2]. - A tripartite supervision agreement has been signed with the sponsor and the bank to regulate the management of the raised funds [1][2]. Fund Usage Status - As of June 30, 2025, the company has not used idle funds for temporary working capital or made any prior investments or replacements with the raised funds [3][4]. - The company has engaged in cash management with idle funds, investing in low-risk financial products, with a total of RMB 60,967,733.33 used in the current year for the IPO funds [3][5]. Project Implementation - The company has not changed the implementation location or method for any fundraising projects, and there are no significant changes in project feasibility [4][5]. - The company has reported that the investment projects related to the IPO are progressing, with specific projects such as the high-speed optical module production line and optical transmission subsystem development experiencing delays [4][5].

Core Viewpoint - The company has approved the use of its own funds to pay for part of the fundraising project expenses, which will later be replaced with equivalent amounts from the raised funds, ensuring efficient management and compliance with regulations [1][5]. Group 1: Fundraising Overview - The company raised a total of RMB 217,149,951.88 through a specific stock issuance, with a net amount verified by an accounting firm [2]. - As of June 30, 2025, the company has utilized RMB 10,538.61 million of the planned investment total of RMB 21,715.00 million for its fundraising projects [2]. Group 2: Use of Own Funds - The company opted to use its own funds for certain project expenses due to restrictions on the fundraising account, particularly for overseas purchases [3][4]. - The process involves documenting transactions and ensuring that the funds are used solely for the intended projects, with a commitment to replace the used funds from the fundraising account within six months [4]. Group 3: Impact and Compliance - This approach is expected to enhance operational efficiency and ensure the smooth progress of fundraising projects without altering the intended use of the funds [4][5]. - The decision was approved by the company's board and audit committee, adhering to relevant legal and regulatory requirements [5].

Fundraising Overview - The company, Wuxi Dekeli Optoelectronic Technology Co., Ltd., has received approval from the China Securities Regulatory Commission for a specific stock issuance, raising a total of RMB 217,149,951.88 after deducting issuance costs [1][2] - The issuance price was set at RMB 63.51 per share, with a par value of RMB 1.00 per share [1] Fund Management and Regulatory Compliance - A special fundraising account has been established at Bank of China (Thailand) for the project "Dekeli Overseas R&D Production Base Construction Project," ensuring compliance with relevant regulations and protecting the interests of minority investors [2][3] - The company has signed a four-party supervision agreement involving itself, the project implementation entity Taclink (Thailand) Co., Ltd., Guotai Junan Securities Co., Ltd., and Bank of China (Thailand) [2][3] Agreement Details - The agreement stipulates that the funds raised must be used solely for the designated project and cannot be diverted for other purposes [3][4] - The supervising party, Guotai Junan Securities, is responsible for ongoing oversight of the fund management and usage, conducting at least biannual inspections [4][5] - The agreement will remain effective until all funds are fully utilized and the account is legally closed [5]

证券代码：603960 证券简称：克来机电 公告编号：2025-037 上海克来机电自动化工程股份有限公司 关于公司募集资金存放与实际使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、募集资金基本情况 （一）实际募集资金金额、资金到账时间 经中国证券监督管理委员会出具的《关于核准上海克来机电自动化工程股份 有限公司公开发行可转换公司债券的批复》(证监许可[2019]2316 号)核准,同意 公司向社会公开发行面值总额 18,000.00 万元可转换公司债券，期限 6 年。上海 克来机电自动化工程股份有限公司（以下简称"公司"）于 2019 年 12 月 2 日公 开发行了 180 万张可转换公司债券，每张面值 100 元，发行总额 18,000.00 万元。 发行方式采用向公司原股东优先配售，原股东优先配售后余额部分（含原股东放 弃优先配售部分）采用网上通过上海证券交易所交易系统向社会公众投资者发售 的方式进行，认购金额不足 18,000.00 万元的部分（含中签投资者放弃缴款认购 部分）由保荐机构（主承 ...